New coil device aims to stop bleeding without surgery

NCT ID NCT07156409

Not yet recruiting Disease control Sponsor: Suzhou Zenith Vascular Scitech Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a special coil device designed to block abnormal blood vessels in the arms or legs. The device is inserted through a small tube and placed into the target vessel to stop blood flow. About 139 people with conditions like bleeding, malformed vessels, or aneurysms will take part. The main goal is to see if the coil can successfully block the vessel safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Peripheral Embolization Coil System (a device that blocks blood flow)
What this could lead to: If it works, this could provide a reliable, minimally invasive option to stop bleeding or treat abnormal blood vessels in the limbs without open surgery.
What could go wrong: This is an early-stage, single-arm study with no comparison group. The device may fail to block the vessel, require repeat procedures, or cause complications like blood clots or vessel damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS FISTULA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arteriovenous hemangioma/malformation congenital arteriovenous fistula

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTERIOVENOUS FISTULA ARTERIOVENOUS MALFORMATION PERIPHERAL ANEURYSM PERIPHERAL ARTERIAL HEMORRHAGE

More trials for these conditions

Other studies related to the condition(s) this trial covers.